DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,643 | +3.0% | 357,174 | -0.4% | 1.66% | +8.0% |
| Q2 2023 | $86,075 | -99.9% | 358,550 | +5.4% | 1.53% | -9.0% |
| Q1 2023 | $85,720,824 | -5.2% | 340,279 | -0.1% | 1.68% | -17.5% |
| Q4 2022 | $90,469,558 | -99.9% | 340,676 | -6.7% | 2.04% | -10.5% |
| Q3 2022 | $94,563,814,000 | +81402.3% | 365,236 | -7.6% | 2.28% | +9.4% |
| Q1 2022 | $116,026,000 | -8.0% | 395,454 | +3.1% | 2.09% | +0.8% |
| Q4 2021 | $126,183,000 | -5.4% | 383,464 | -12.5% | 2.07% | -6.4% |
| Q3 2021 | $133,408,000 | +14.3% | 438,397 | +0.8% | 2.21% | +55.6% |
| Q2 2021 | $116,760,000 | +19.6% | 435,119 | +0.3% | 1.42% | -27.3% |
| Q1 2021 | $97,642,000 | +6.6% | 433,607 | +4.9% | 1.95% | -5.2% |
| Q4 2020 | $91,638,000 | -8.7% | 413,318 | -11.3% | 2.06% | -24.2% |
| Q3 2020 | $100,335,000 | – | 466,113 | – | 2.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |